Nephrocare Health Services IPO GMP & Review: Apply or Avoid?

Nephrocare Health Services IPO is open for bidding from 10th December 2025 to 12th December 2025. It is a bookbuilding IPO of ₹871.05 crore, an entirely fresh issue of 0.77 crore shares, and the offer for sale is 1.13 crore shares. The issue will be listed on BSE and NSE on its tentative listing date, 17th December 2025. 

Nephrocare Health Services IPO Details 

The Nephrocare Health Services IPO date is fixed between 10th December 2025 and 12th December 2025. The face value of Nephrocare Health Services shares stands at ₹2 per share, and the IPO Issue price band is set at ₹438 to ₹460 per share

Kfin Technologies Limited is the registrar of the Nephrocare Health Services IPO and is responsible for managing the allotment process and initiating refunds. Check out the latest IPO details in the table below. 

Nephrocare Health Services IPO Share Reservation

Riddhi Display Equipment’s IPO is a bookbuilding IPO issue of 0.77 crore worth ₹871.05 crores. Nephrocare Health Services IPO Limited shares will be listed on the BSE and the NSE. Furthermore, SEBI has specified the share reservation criteria for different investor categories. 

Nephrocare Health Services IPO GMP Grey Market Premium

GMP is the gap between the issue price band and the price at which company shares are currently trading in the grey market. Do you want to get live updates on the Nephrocare Health Services IPO? If yes, then you’ve reached the right spot. Check the table below to learn about the GMP trends.

As of 10th December 2025, Nephrocare Health Services IPO GMP stands at ₹0 per share, which means the share will likely show a listing at ₹460.00 on its tentative listing date, 17th December 2025.

GMP data is subject to change based on market trends and sentiments. You should check the live GMP status before applying for the Nephrocare Health Services IPO GMP. Stay informed with Univest for real-time insights into IPOs and their GMP trends. 

Nephrocare Health Services IPO GMP Review

Check out the detailed Nephrocare Health Services GMP IPO review for a thorough understanding of its potential to report listing gains on 17th December 2025. The Nephrocare Health Services IPO review below will help you invest effectively to avoid significant losses. Explore more to make informed investment decisions on this IPO. 

Financial Health

Assess a company’s financial performance to know about its ability to sustain a competitive edge. Thus, it is essential to understand the business’s economic growth and decline before applying for the Nephrocare Health Services IPO.

Nephrocare Health Services Limited’s revenue increased by 34% from ₹574.72 crores in March 2024  to ₹769.92 crores in March 2025. Moreover, the company’s PAT increased by 91% from ₹35.13 crores in March 2024 to ₹67.10 crores in March 2025.

Nephrocare Health Services’ IPO has shown consistent revenue growth, indicating the company’s financial stability. Moreover, the brokers, investors, and RAs have a positive outlook for the Nephrocare Health Services IPO for its tentative listing day, which is 17th December 2025. 

Technical Analysis

Several technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technicals of the Nephrocare Health Services IPO.

The PE ratio of Nephrocare Health Services Limited shares is 63.52, and its Earnings Per Share (EPS) stands at 7.24. Thus, the Nephrocare Health Services IPO can deliver gains on its tentative listing date, 17th December 2025. 

Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Nephrocare Health Services Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics. 

Nephrocare Health Services IPO Subscription Status

The Nephrocare Health Services IPO is to be opened for bidding on 10th December 2025. The subscription status for this IPO is yet to be announced. Stay informed on this passage to check the live Nephrocare Health Services IPO Subscription Status. 

About Nephrocare Health Services Limited

Nephrocare Health Services was established in 2010. Nephrocare Health Services Ltd. provides end-to-end dialysis care through a vast network of clinics across India and select international markets. The company offers services including diagnosis, haemodialysis, home and mobile dialysis, and wellness programs, supported by an in-house pharmacy. As of Sep 30, 2025, Nephrocare operated 519 clinics with 51 across the Philippines, Uzbekistan, and Nepal. This includes the world’s largest dialysis clinic in Uzbekistan. In India, the company had a presence across 288 cities in 21 States and 4 Union Territories. Approximately 77.53% of its clinics were located in tier II and tier III cities, addressing a critical need in underserved regions. During Fiscal 2025, Nephrocare served 29,281 patients and completed 2,885,450 dialysis treatments, accounting for roughly 10% of the country’s total dialysis patient base. Additionally, by Sep 30, it has served 31,046 patients and completed 1,591,377 treatments in India. As of Sep 30, 2025, the company has 5,562 dialysis machines.

Nephrocare Health Services Limited Financials

The company’s financial analysis is essential before applying for the Nephrocare Health Services IPO. Look at the table to learn about Nephrocare Health Services Limited’s financials. 

Explanation

Nephrocare Health Services Limited’s revenue increased by 34% from ₹574.72 crores in March 2024  to ₹769.92 crores in March 2025. Moreover, the company’s PAT increased by 91% from ₹35.13 crores in March 2024 to ₹67.10 crores in March 2025.

Nephrocare Health Services Limited IPO Promoter Holdings

Have a look at the table below to check the holdings of Nephrocare Health Services Limited.

Mr Hitesh Kumar Singla, Mr Nikhil Singla, Mr Nitin Dixit, and Mr Anil Kumar Sharma.

Note: The value will be calculated using Equity Dilution = Share Holding Pre Issue – Share Holding Post Issue.

Aim of Nephrocare Health Services IPO

The primary aim of the Nephrocare Health Services IPO is to raise ₹871.05 crores. On the other hand, Nephrocare Health Services has decided to utilise these funds in different ways.

• To Capital expenditure by the Company for opening new dialysis clinics in India
• To Pre-payment, or scheduled repayment, in whole or part, of certain borrowings availed by the Company
• For general corporate purposes

Should I Invest in the Nephrocare Health Services IPO?

Explore the pros and cons of Nephrocare Health Services to know whether you should apply or avoid the issue. These pros and cons might help you understand the IPO’s efficiency in delivering profits over the coming decades. 

Pros of Nephrocare Health Services IPO

• The company has the largest dialysis chain with leadership across our markets.
• The company has a track record of sustainable growth, profitability and return.
• The company has organic growth augmented by a proven track record of acquisitions and integration in India and internationally.

Cons of Nephrocare Health Services IPO

• The company has heavy dependence on captive clinics & PPC contracts
• The company has operational, regulatory and medical service risks
• The company has financial risks, working capital and cost pressure exposure

How to Apply for Nephrocare Health Services IPO?

Check the steps mentioned below to apply for Nephrocare Health Services Ltd.

• Step 1: Conduct thorough research on the Nephrocare Health Services IPO GMP, subscription status, issue size, lot size, and other details. 
• Step 2: Open a demat account with Univest to access real-time insights on GMP and subscription status. You can also use your previous demat account by navigating to the IPO section. 
• Step 3: Make a bid for 1 lot of 32 shares worth ₹14,720
• Step 4: You will receive a mandate request after making a bid. Approve the request to proceed further.    

Note: You can apply for the Nephrocare Health Services IPO across multiple demat accounts to increase your chances of allotment. 

How to Check Nephrocare Health Services IPO Allotment Status?

You can check for the Nephrocare Health Services IPO allotment in different ways. These include NSE and the registrar portal. Follow the steps below to check your allotment status online.

Check On BSE

• Visit the BSE Official Site
• Navigate to the IPO Allotment Section. 
• Select Equity as the issue type. 
• Choose the Nephrocare Health Services IPO.  
• Choose whether to proceed with the PAN number or the application number.
• Submit your details to get the allotment status online. 

Check On the Registrar Portal

• Visit the registrar portal.
• Click on the allotment option.
• Fill in the required details.
• Click on the submit button to know your Nephrocare Health Services IPO allotment status.

Let’s Wrap

Nephrocare Health Services IPO is a bookbuilding issue of shares worth ₹871.05 crores. The shares of Nephrocare Health Services Limited will be listed on BSE and NSE on its tentative listing date of 17th December 2025. Researching the Nephrocare Health Services IPO GMP and reviews is highly recommended to achieve your desired profitability. Brokers and investors have highlighted their pros and cons, so one must analyse them and decide accordingly.

Open a demat account on Univest now to initiate your investment journey!

FAQs on Nephrocare Health Services IPO

How is the Nephrocare Health Services IPO?

Ans. Currently, on 10th December 2025, the Nephrocare Health Services GMP (Grey Market Premium) stands at ₹0. It indicates that the estimated listing price could be ₹460.00 per share. It is a bookbuilding IPO of ₹871.05 shares. The face value of each Nephrocare Health Services share is ₹2 per share. 

What is the Nephrocare Health Services IPO price?

Ans. The Nephrocare Health Services IPO issue price band is set at ₹438.00 to ₹460.00 per share. 

Is the Nephrocare Health Services IPO a good investment?

Ans. Nephrocare Health Services Limited’s revenue increased by 34% from ₹574.72 crores in March 2024  to ₹769.92 crores in March 2025. Moreover, the company’s PAT increased by 91% from ₹35.13 crores in March 2024 to ₹67.10 crores in March 2025.

Who is the registrar of the Nephrocare Health Services IPO?

Ans. Kfin Technologies Limited is the registrar for the Nephrocare Health Services IPO, awaiting to manage the allotment process and initiate refunds. For any queries regarding the Nephrocare Health Services allotment and refund, you can contact Kfin Technologies Limited at nephrocare.ipo@kfintech.com or at 04067162222 or 04079611000.

What is the issue size of the Nephrocare Health Services IPO? 

Ans. Nephrocare Health Services IPO is a bookbuilding IPO for ₹871.05 shares. Moreover, the IPO is set to open on 10th December 2025 and will be closed on 12th December 2025. 

Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Nephrocare Health Services IPO, download the Nephrocare Health Services IPO RHP and Nephrocare Health Services  IPO DRHP. Conduct your research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.

Upcoming IPOs

Current & Previous IPOs

Read Our Articles on the Best Stocks

Tech Stocks in India to Invest in 2025 | Tech Sector Stocks 

Best Battery Stocks in India to Invest in 2025 | Battery Sector Stocks 

Best Shipping Stocks in India to Invest in 2025 | Shipping Sector Stocks 

Paint Stocks in India to Invest in 2025 | Paint Sector Stocks 

Paper Stocks in India to Invest in 2025 | Paper Sector Stocks 

Best Semiconductor Stocks in India 2025 

Best Large Cap Stocks in India 2025 

Green Energy Penny Stocks

Best Cement Stocks To Invest In India

Also Explore

Univest Screeners

Explore Webstories on Univest 

1. Best Time To Buy Dividend Stocks

2. How RBI Policies Affect Dividend Stocks

3. Can Dividend Stocks Beat Inflation

4. What Is The Dividend Aristocrat List

5. Which Indian Psus Offer The Best Dividends

6. Large Cap Vs Small Cap Dividend Stocks